Prognostic value of miR-93 overexpression in resectable gastric adenocarcinomas

Acta Gastro-Enterologica Belgica

Volumn 75, Issue 1, 2012, Pages 22-27

  Chen, Ling ^a,b   Jiang, Meng ^a   Yuan, Weijie ^a   Tang, Huihuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Clinicopathological features; Gastric cancer; MiR 93; MiRNA; Prognosis

Indexed keywords

MICRORNA; MICRORNA 93; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; GASTRECTOMY; GENE OVEREXPRESSION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH ADENOCARCINOMA; UPREGULATION;

ADENOCARCINOMA; ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; UP-REGULATION;

EID: 84863363913     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. DICKEN B.J., BIGAM D.L., CASS C., MACKEY J.R., JOY A.A., HAMILTON S.M. Gastric adenocarcinoma: review and considerations for future directions. Ann. Surg., 2005, 241: 27-39.
2. WHELAN S. L. Cancer Incidence in Five Continents. Coding practices. IARC Sci. Publ., 1992, 120: 31-38.
3. PARKIN D.M., BRAY F., FERLAY J., PISANI P. Global cancer statistics, 2002. CA Cancer J. Clin., 2005, 55: 74-108.
4. INOUE M., TSUGANE S. Epidemiology of gastric cancer in Japan. Postgrad. Med. J., 2005, 81: 419-24.
5. JEMAL A., SIEGEL R., WARD E., HAO Y., XU J., THUN M.J. Cancer Statistics, 2009. CA Cancer J. Clin., 2009, 59: 225-249.
6. XU D.Z., GENG Q.R., LONG Z.J., ZHAN Y.Q., LI W., ZHOU Z.W. et al. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes. Ann. Surg. Oncol., 2009, 16: 319-326.
7. MARRELLI D., DE STEFANO A., DE MANZONI G., MORGAGNI P., DI LEO A., ROVIELLO F. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann. Surg., 2005, 241: 247-255.
8. KATTAN M.W., KARPEH M.S., MAZUMDAR M., BRENNAN M.F. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J. Clin. Oncol., 2003, 21: 3647-3650.
9. SIEWERT J.R., BOTTCHER K., STEIN H.J., RODER J.D. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann. Surg., 1998, 228: 449-461.
10. YASUI W., OUE N., AUNG P.P., MATSUMURA S., SHUTOH M., NAKAYAMA H. Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer, 2005, 8: 86-94.
11. LIU K., WANG G.F., DING H.Z., CHEN Y., YU G.Z., WANG J.J. Downregulation of metastasis suppressor 1 (MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer. BMC Cancer, 2010, 10: 428.
12. BARTEL D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell., 2004, 116: 281-97.
13. FABBRI M., CROCE C.M., CALIN G.A. MicroRNAs. Cancer J., 2008, 14: 1-6.
14. HE L, HANNON G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet., 2004, 5: 522-531.
15. DEWS M., HOMAYOUNI A., YU D., MURPHY D., SEVIGNANI C., WENTZEL E. et al. Augmentation of tumor angiogenesis by a Myc- activated microRNA cluster. Nat. Genet., 2006, 38: 1060-5.
16. CALIN G.A., SEVIGNANI C., DUMITRU C.D., HYSLOP T., NOCH E., YENDAMURI S. et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA, 2004, 101: 2999-3004.
17. TSUKAMOTO Y., NAKADA C., NOGUCHI T., TANIGAWA M., NGUYEN L.T., UCHIDA T. et al. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res., 2010, 70: 2339-49.
18. CALIN G.A., FERRACIN M., CIMMINO A., DI LEVA G., SHIMIZU M., WOJCIK S.E. et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med., 2005, 353: 1793-801.
19. LI X., ZHANG Y., ZHANG Y., DING J., WU K., FAN D. Survival prediction of gastric cancer by a seven-microRNA signature. Gut, 2010, 59: 579-85.
20. FANG L., DENG Z., SHATSEVA T., YANG J., PENG C., DU W.W. et al. MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8. Oncogene, 2011, 30: 806-21.
21. LI Y., TAN W., NEO T.W., AUNG M.O., WASSER S., LIM S.G. et al. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci., 2009, 100: 1234-42.
22. CHAVALI P.L., FUNA K., CHAVALI S. Cis-regulation of microRNA expression by scaffold/matrix-attachment regions. Nucleic. Acids. Res., 2011, in press.
23. DU L., SCHAGEMAN J.J., SUBAUSTE M.C., SABER B., HAMMOND S.M., PRUDKIN L. et al. miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Mol. Cancer Res., 2009, 7: 1234-43.
24. LI Y., TAN W., NEO T.W., AUNG M.O., WASSER S., LIM S.G. et al. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci., 2009, 100: 1234-42.
25. YAO J., LIANG L., HUANG S., DING J., TAN N., ZHAO Y. et al. MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Hepatology, 2010, 51: 846-56.
26. QIU H.B., ZHANG L.Y., KESHARI R.P., WANG G.Q., ZHOU Z.W., XU D.Z. et al. Relationship between H. Pylori infection and clinicopatholo-gical features and prognosis of gastric cancer. BMC Cancer, 2010, 10: 374.
27. UEDA T., VOLINIA S., OKUMURA H., SHIMIZU M., TACCIOLI C., ROSSI S. et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol., 2010, 11: 136-46.
28. LIANG S., HE L., ZHAO X., MIAO Y., GU Y., GUO C. et al. MicroRNA Let-7f Inhibits Tumor Invasion and Metastasis by Targeting MYH9 in Human Gastric Cancer. PLoS One, 2011, 6: e18409.
29. OTSUBO T., AKIYAMA Y., HASHIMOTO Y., SHIMADA S., GOTO K., YUASA Y. MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis. PLoS One, 2011, 6: e16617.
30. LEWIS B.P., BURGE C.P., BARTEL D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell., 2005, 120: 15-20.
31. WANG Z., LIU M., ZHU H., ZHANG W., HE S., HU C. et al. Suppressionof p21 by c-Myc through members of miR-17 family at the post-transcriptional level. Int. J. Oncol., 2010, 37: 1315-21.
32. KIM Y.K., YU J., HAN T.S., PARK S.Y., NAMKOONG B., KIM D.H. et al. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic. Acids. Res., 2009, 37: 1672-81.
33. NAM E.J., YOON H., KIM S.W., KIM H., KIM Y.T., KIM J.H. et al. MicroRNA expression profiles in serous ovarian carcinoma. Clin. Cancer Res., 2008, 14: 2690-5.
34. PETROCCA F., VISONE R., ONELLI M.R., SHAH M.H., NICOLOSO M.S., DE MARTINO I. et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell., 2008, 13: 272-86.
35. ZHANG X., YAN Z., ZHANG J., GONG L., LI W., CUI J. et al. Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection. Ann. Oncol., 2011, in press.
36. KATADA T., ISHIGURO H., KUWABARA Y., KIMURA M., MITUI A., MORI Y. et al. microRNA expression profile in undifferentiated gastric cancer. Int. J. Oncol., 2009, 34: 537-42.
37. BANDRES E., BITARTE N., ARIAS F., AGORRETA J., FORTES P., AGIRRE X. et al. microRNA-451 regulates macrophage migration inhibitory fac tor production and proliferation of gastrointestinal cancer cells. Clin. Cancer Res., 2009, 15: 2281-90.
38. MITCHELL P.S., PARKIN R.K., KROH E.M., FRITZ B.R., WYMAN S.K., POGOSOVA-AGADJANYAN E.L. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA, 2008, 105: 10513-10518.